CRYSTAL STRUCTURES OF ANTIBODIES AND IDIOTYPIC CASCADE
CRYSTAL STRUCTURES OF ANTIBODIES AND IDIOTYPIC CASCADE
批准号:
2806551
负责人:
BRADFORD C BRADEN
金额:
$9.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2003-12-31
中文摘要
说明(改编自《调查员摘要》):建议
探讨抗体/抗原识别的分子机制。
两种相关抗鸡蛋蛋白的X射线晶体结构测定
溶菌酶(HEL)抗体D44.1和F10.6.6,表现出显著的
对抗原亲和力的差异。FV的结构
这两个抗体的片段将详细说明分子间
相互作用,稳定抗体抗原复合体,形成
抗体对抗原的分子识别。分析了两个这样的问题
密切相关的抗体可以帮助理解分子
微调的亲和成熟反应的基础。它更远了
建议通过以下方式剖析独特型网络的结构基础
两种抗独特型和抗独特型药物的晶体结构分析
抗体AF14和AF52。这些抗-抗-ID的结构
抗体,结合先前对病毒结构的分析
抗原(HEL)、抗体(D1.3)和抗id抗体(E5.2)将提供
独特型网络的第一个详细的分子机制。完整的
披露这种独特型级联将极大地帮助应用程序
抗id抗体,模拟抗原,用作免疫化学和
药理制剂。分子模仿是一种普遍存在的现象
生物学,是许多药学活动的基础
有用的化合物,如管库仑和多环阿片类药物。
抗体为研究分子模仿提供了一个强有力的工具,因为
某些抗独特型抗体已被证明在功能上模仿
抗原。HEL(抗原)-D1.3(抗体)-E5.2(抗id)-AF14、AF52
(反身份证)系统将提供这样的工具。最后,提出了一种新的研究思路。
用X射线结晶学方法研究大分子组装
以及这种结构与其催化机制的关系
一种鲁马津合成酶,核黄素生产中的关键酶,从
布鲁氏菌。细菌缺乏一种摄取系统
核黄素。因此,它们依赖于
这种辅酶应该很容易受到核黄素抑制剂的影响
综合。由于卢马津合成酶在哺乳动物中不存在,因此
对其三维结构的了解可以作为
具有治疗活性的酶抑制剂的合理设计。
英文摘要
DESCRIPTION (Adapted from the Investigator's Abstract): It is proposed
to investigate the mechanism of antibody/antigen recognition by
determining the X-ray crystal structures of two related anti-hen egg
lysozyme (HEL) antibodies, D44.1 and F10.6.6, that exhibit remarkable
differences in affinity for the antigen. The structures of the Fv
fragments of these two antibodies will detail the intermolecular
interactions, which stabilize the antibody antigen complex and form the
molecular recognition of antibody for antigen. Analysis of two such
closely related antibodies can serve the understanding of the molecular
basis of the fine-tuned affinity maturation response. It is further
proposed to dissect the structural basis of idiotypic networks by
analyzing the crystal structures of two anti-anti-idiotypic and
antibodies, AF14 and AF52. The structures of these anti-anti-Id
antibodies, in concert with the prior analysis of the structures of the
antigen (HEL), antibody (D1.3) and anti-id antibody (E5.2), will provide
the first detailed molecular mechanism of idiotypic networks. The full
disclosure of this idiotypic cascade will greatly aid in the application
of anti-id antibodies, mimicking antigens, for use as immunochemical and
pharmacological agents. Molecular mimicry is a widespread phenomenon in
biology and is the basis for the activity of many pharmaceutically
useful compounds such as tubocurare and the polycyclic opiods.
Antibodies offer a powerful tool for studying molecular mimicry since
certain anti-idiotypic antibodies have been shown to functionally mimic
antigens. The HEL (antigen)-D1.3 (antibody)-E5.2 (anti-id)-AF14,AF52
(anti-anti-Ids) system will offer such a tool. Finally, it is proposed
to study, by X-ray crystallographic methods, the macromolecular assembly
and the relationship of that structure to the mechanism of catalysis of
a lumazine synthase, a key enzyme in the production of riboflavin, from
Brucella bacterium. Bacteria are devoid of an uptake system for
riboflavin. They are therefore dependent of the internal synthesis of
this co-enzyme and should be vulnerable to inhibitors of riboflavin
synthesis. Since lumazine synthase is not present in mammals, the
knowledge of its three-dimensional structure could serve as a basis for
the rational design of enzymatic inhibitors with therapeutic activity.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Structural, functional and immunological studies on a polymeric bacterial protein.
聚合细菌蛋白的结构、功能和免疫学研究。
DOI:
10.1590/s0100-879x2000000700003
发表时间:
2000
期刊:
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
影响因子:
--
作者:
[Baldi,PC, Velikovsky,CA, Braden,BC, Giambartolomei,GH, Fossati,CA, Goldbaum,FA]
通讯作者:
Goldbaum,FA
Structural, thermodynamic and kinetic studies of antibo*
-
批准号:6530088
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2001
-
负责人:BRADFORD C BRADEN
-
依托单位:
Structural, thermodynamic and kinetic studies of antibo*
-
批准号:6644845
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2001
-
负责人:BRADFORD C BRADEN
-
依托单位:
Structural, thermodynamic and kinetic studies of antibo*
-
批准号:6402341
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2001
-
负责人:BRADFORD C BRADEN
-
依托单位:
海外基金